ARTICLE SUMMARY:
Private financings in the medtech world for the October 2025, a quiet month in terms of deal volume. In this issue we include investments made in the cardiovascular, cancer, brain-monitoring, women's health, orthopedics, and autoimmune disease segments.
October’s medtech private financing landscape was quieter than usual but far from dull, highlighted by a blockbuster round for CoMind, the London-based company developing a new noninvasive way to monitor brain activity. This month’s investor snapshot profiles Parkwalk Advisors, a London-based firm backing deep science and university spinouts.
